986 



SUBJECT INDEX 



heart, 211-224 



hematopoietic depression, 250 

 hydrolysis of, 7-8 

 hyperglycemia, 247-250 

 hyperpnea, 232, 246 

 intestinal transports, 175-179, 189-191 

 intestine, 224-226, 251 

 ionization, 8-9 

 I~ release in vivo, 245 

 kidney damage, 251 

 lactate dehydrogenase, 28-29 

 lactate oxidation, 6, 87-88 

 lens, 239 



lethal doses, 251-252 

 lipid metabolism, 140-146 

 lipoate levels in tissues, 96 

 membrane potentials, 193, 206-208, 

 217-221, 225, 230 

 mitosis, 253-255 

 muscle, 3-4, 195-210, 271 

 myelin structure, 230 

 nerve, 228-230 



neuromuscular transmission, 209-210 

 nitrate reduction, 148, 154-155 

 nitrogen fixation, 148 

 nucleic acid biosynthesis, 253 

 osteoporosis, 251 



oxidative phosphorylation, 60-61, 274 

 partition coefficients, 9 

 pentose-P pathway, 125-132 

 permeability to, 13, 168-171, 271 

 phagocytosis, 240-242 

 pH changes in tissues, 82-84, 262 

 pH effects on inhibitions, 168-171 

 phosphate uptake, 98-99 

 3-phosphoglyceraldehyde dehydroge- 

 nase, 6-7, 18-25 



phospholipid biosynthesis, 145-146 

 phosphorus metabolism, 98-100, 139 

 photophosphorylation, 157 

 photosynthesis, 156-166 

 plant growth, 255-258 

 polysaccharide biosynthesis, 82, 133, 

 136, 138, 253 



porphyrin biosynthesis, 155-156 

 preparation of, 8 



protein biosynthesis, 147-148, 253 

 proteolytic enzymes, 39-45 



protoplasmic streaming, 242 

 protozoa, 270 

 purification of, 8 

 purine biosynthesis, 253 

 purity of, 8 



pyruvate antagonism of inhibitions, 

 214 



pyruvate fermentation, 5 

 pyruvate oxidation, 89, 93-96 

 radiation susceptibility, 265-266 

 reaction with amino acids, 13-15 

 reaction with proteins, 14-18 

 reaction with thiols, 9-13 

 renal transports, 191-193 

 respiration (endogenous), 109-122 

 respiration (glucose), 5-6, 87, 93, 111, 

 122, 241, 262 



respiratory quotient, 5, 111, 133-135 

 retina, 232-239 

 ribonuclease, 32-34 

 salivary secretion, 240 

 skin, 243-244 



specificity of, 52, 63, 69-73, 96-97, 167- 

 168 



spermatogenesis, 250 

 spermatozoa, 242-243 

 stability of, 7-8 

 sterol biosynthesis, 145 

 sucrose biosynthesis, 136 

 succinate dehydrogenase, 29-32 

 sulfur oxidation, 155 

 tissue distribution of, 244-246 

 titration of enzyme SH groups, 38-39 

 titration of protein SH groups, 14-16 

 toxicity, 244, 246-252, 265-266 

 tricarboxylate cycle, 87-98 

 trypanosomiasis, 270 

 urea cycle, 148 

 urinary amino acids, 321 

 urinary flow, 192-193, 321 

 urinary keto acids, 321 

 uterus, 226 



vascular smooth muscle, 226-227 

 vesication, 243-244 

 viruses, 267-269 

 yeast growth, 269 

 lodoacetate esters, 



enzyme inhibitions, 278 



